Agnes Janoshazi

Summary

Country: France

Publications

  1. doi Protein kinase C as a peripheral biomarker for Alzheimer's disease
    Jean de Barry
    Institut des Neurosciences Cellulaires et Integratives, CNRS, Strasbourg, France
    Exp Gerontol 45:64-9. 2010
  2. ncbi Alteration of protein kinase C conformation in red blood cells: a potential marker for Alzheimer's disease but not for Parkinson's disease
    Agnes Janoshazi
    Neurotransmission et Sécretion Neuroendocrine UPR2356 CNRS, Strasbourg, France
    Neurobiol Aging 27:245-51. 2006
  3. ncbi F-actin does not modulate the initial steps of the protein kinase C activation process in living nerve cells
    Virginie Geeraert
    Neurotransmission et Secretion Neuroendocrine, UPR 2356 CNRS, 5 rue B Pascal, F 67084 Strasbourg CEDEX, France
    Exp Cell Res 289:222-36. 2003
  4. ncbi The natural mutation encoding a C terminus-truncated 5-hydroxytryptamine 2B receptor is a gain of proliferative functions
    Maud Deraet
    INSERM U616 Hospital Pitié Salpetrière, Bâtiment Pédiatrie, 47 Boulevard de l Hopital, 75651 Paris Cedex 13, France
    Mol Pharmacol 67:983-91. 2005

Collaborators

  • Ludovic Drouet
  • Jean de Barry
  • Maud Deraet
  • Virginie Geeraert
  • Corinne Mbebi Liégeois
  • Jacques Callebert
  • Luc Maroteaux
  • Philippe Manivet
  • Silke Guenther
  • Jean Marie Launay
  • Sylvette Chasserot-Golaz
  • Jean Luc Dupont
  • Odile Procksch
  • Céline Huvet
  • Nancy J Grant

Detail Information

Publications4

  1. doi Protein kinase C as a peripheral biomarker for Alzheimer's disease
    Jean de Barry
    Institut des Neurosciences Cellulaires et Integratives, CNRS, Strasbourg, France
    Exp Gerontol 45:64-9. 2010
    ..Such probes can be used to detect PKC alterations in red blood cells and thus to distinguish AD patients from healthy controls with unmatched specificity and sensitivity...
  2. ncbi Alteration of protein kinase C conformation in red blood cells: a potential marker for Alzheimer's disease but not for Parkinson's disease
    Agnes Janoshazi
    Neurotransmission et Sécretion Neuroendocrine UPR2356 CNRS, Strasbourg, France
    Neurobiol Aging 27:245-51. 2006
    ..If PKC alteration is proven to be specific to AD as compared with other dementia, this method could be for a simple, low cost screening test among patients suspected of having AD and may have a strong predictive value...
  3. ncbi F-actin does not modulate the initial steps of the protein kinase C activation process in living nerve cells
    Virginie Geeraert
    Neurotransmission et Secretion Neuroendocrine, UPR 2356 CNRS, 5 rue B Pascal, F 67084 Strasbourg CEDEX, France
    Exp Cell Res 289:222-36. 2003
    ..These results suggest that the actin network is not involved in the initial steps of the PKC activation process in living nerve cells...
  4. ncbi The natural mutation encoding a C terminus-truncated 5-hydroxytryptamine 2B receptor is a gain of proliferative functions
    Maud Deraet
    INSERM U616 Hospital Pitié Salpetrière, Bâtiment Pédiatrie, 47 Boulevard de l Hopital, 75651 Paris Cedex 13, France
    Mol Pharmacol 67:983-91. 2005
    ..All these modifications are relevant in pathophysiological vasoconstriction...